PARP-1 controls Snail expression at thetranscriptional level in cells exposed to doxorubicin, and ABT-888, a PARP-1inhibitor, is able to enhance the response of BC cells (MDA-MB-231 line) todoxorubicin. This evidence concerns the gene SNAI1 and breast cancer.